 |
N-acetyl cysteine amide |
|---|---|
| Trade Name | |
| Orphan Indication | Retinitis pigmentosa |
| USA Market Approval | USA |
| USA Designation Date | 2013-12-31 00:00:00 |
| Sponsor | Nacuity Pharmaceuticals, Inc.;Fort Worth Club Building, 306 W 17th Street;Fort Worth, Texas, 76106 |
Related Access Program